• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    GSK to buy US biotech firm IDRx for up to $1.15 billion

    PRESS RELEASE

    IDRx Updates Phase 1 Data for IDRX-42 in GIST at CTOS 2024

    BUSINESSWIRE

    IDRx Announces $120M Series B Financing For GIST Treatment Development

    BUSINESSWIRE

    IDRx`s IDRX-42 Shows Best-In-Class Potential In GIST Phase 1 Data

    BUSINESSWIRE

    IDRx Appoints David P. Kerstein, M.D., as Chief Medical Officer

    BUSINESSWIRE

    IDRx Strengthens Executive Team

    BUSINESSWIRE

    IDRx Presents Preliminary Clinical Data from Ongoing Phase 1 StrateGIST Study

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.